ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,068Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 2056

$437K Total Retail Price of All Prescriptions

Rank: 109 out of 2056

372 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

15% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 509 438 1 3
LOSARTAN POTASSIUM 459 418 2 13
SIMVASTATIN 458 405 3 2
POTASSIUM CHLORIDE 374 365 4 18
LISINOPRIL 362 311 5 1
OMEPRAZOLE 353 294 6 4
HYDROCODONE-ACETAMINOPHEN 326 238 S3 7 5
FUROSEMIDE 300 284 8 9
HYDROCHLOROTHIAZIDE 237 226 9 7
METFORMIN HCL 200 193 10 8
ALENDRONATE SODIUM 199 182 11 26
CARVEDILOL 196 185 12 35
CRESTOR 194 186 13 30
AMLODIPINE BESYLATE 177 173 14 6
METOPROLOL TARTRATE 131 127 15 11
WARFARIN SODIUM 130 129 16 12
DIGOXIN 128 128 17 53
METFORMIN HCL ER 128 105 17 43
ALLOPURINOL 127 116 19 32
ZOLPIDEM TARTRATE 127 114 19 23
SPIRONOLACTONE 120 113 21 63
PRAVASTATIN SODIUM 120 86 21 20
SERTRALINE HCL 113 109 23 25
TAMSULOSIN HCL 109 107 24 28
ACTOS 103 96 25 119
ESTRADIOL 100 81 R 26 85
VERAPAMIL ER 96 96 27 128
METOPROLOL SUCCINATE 89 63 28 19
TRAZODONE HCL 89 60 28 21
PROAIR HFA 89 67 28 29
GABAPENTIN 83 67 31 14
LANTUS 83 80 31 41
ATORVASTATIN CALCIUM 81 73 33 17
TRAMADOL HCL 80 55 34 27
ATENOLOL 78 59 35 10
JANTOVEN 73 73 36 148
PANTOPRAZOLE SODIUM 70 70 37 55
CITALOPRAM HBR 70 60 37 15
ROPINIROLE HCL 66 62 39 98
GLIPIZIDE 59 55 40 39
ISOSORBIDE MONONITRATE ER 59 42 40 87
PREMARIN 57 44 R 42 177
DONEPEZIL HCL 57 54 42 37
FENTANYL 56 56 S2 44 56
KLOR-CON M20 55 55 45 173
KLOR-CON 10 51 45 46 151
PREDNISONE 50 49 47 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.